Quality of life and performance status from a sub-study conducted within a prospective phase III randomized trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for locally advanced head and neck carcinoma: NRG Oncology RTOG 0522

PURPOSE: To analyze the quality of life (QOL) and performance status (PS) (secondary outcome) of stage III-IV head and neck cancer (HNC) patients enrolled on a prospective randomized phase III trial, comparing radiation-cisplatin without (CIS) or with cetuximab (CET/CIS). The QOL hypothesis proposed...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Radiat Oncol Biol Phys
Главные авторы: Truong, Minh Tam, Zhang, Qiang, Rosenthal, David I., List, Marcie, Axelrod, Rita, Sherman, Eric, Weber, Randal, Nguyen-Tân, Phuc Felix, El-Naggar, Adel, Konski, André, Galvin, James, Schwartz, David, Trotti, Andy, Silverman, Craig, Singh, Anurag, Godette, Karen, Bonner, James A., Jones, Christopher U., Garden, Adam S., Shenouda, George, Matthiesen, Chance, Le, Quynh-Thu, Bruner, Deborah
Формат: Artigo
Язык:Inglês
Опубликовано: 2016
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5303682/
https://ncbi.nlm.nih.gov/pubmed/27727066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2016.08.003
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы